Clinical trialNCT00239681TerminatedPhase 3Interventional

JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events

SponsorAstraZenecaEnrollment17,802Elevated High-sensitivity C-Reactive Protein (hsCRP)

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Judith Hsia, MD
AstraZeneca
Study Director
clinicaltrials.gov ↗
Paul Ridker, MD
Brigham and Women's Hospital
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

856 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina

Research Site
Capital Federal, Buenos Aires, Argentina
Research Site
Pilar, Buenos Aires, Argentina
Research Site
Quilmes, Buenos Aires - Argentina, Argentina
Research Site
Ramos Mejía, Buenos Aires Argentina, Argentina
Research Site
San Isidro, Buenos Aires- Argentina, Argentina
Research Site
Córdoba, Cordoba - Argentina, Argentina
Research Site
Salta, Salta Province, Argentina
Research Site
Rosario, Santa Fe- Argentina, Argentina
Research Site
San Miguel de Tucumán, Tucuman / Argentina, Argentina
Research Site
San Miguel de Tucumán, Tucuman-argentina, Argentina

Belgium

Research Site
Alsemberg, Belgium, Belgium
Research Site
Anthée, Belgium, Belgium
Research Site
Auvelais, Belgium, Belgium
Research Site
Baisy-Thy, Belgium, Belgium
Research Site
Bertrix, Belgium, Belgium
Research Site
Betekom, Belgium, Belgium
Research Site
Boechout, Belgium, Belgium
Research Site
Braine-l'Alleud, Belgium, Belgium
Research Site
Burdinne, Belgium, Belgium
Research Site
Cerexhe-Heuseux, Belgium, Belgium
Research Site
Champion, Belgium, Belgium
Research Site
Chênée, Belgium, Belgium
Research Site
Comines, Belgium, Belgium
Research Site
Deurne (antwerpen), Belgium, Belgium
Research Site
Dour, Belgium, Belgium
Research Site
Embourg, Belgium, Belgium
Research Site
Genk, Belgium, Belgium
Research Site
Genly, Belgium, Belgium
Research Site
Gozée, Belgium, Belgium
Research Site
Grivegnée, Belgium, Belgium
Research Site
Halen, Belgium, Belgium
Research Site
Hasselt, Belgium, Belgium
Research Site
Heurne, Belgium, Belgium
Research Site
Heusden, Belgium, Belgium
Research Site
Hove, Belgium, Belgium
Research Site
Kessel-Lo, Belgium, Belgium
Research Site
Kraainem, Belgium, Belgium
Research Site
Landen, Belgium, Belgium
Research Site
Leopoldsburg, Belgium, Belgium
Research Site
Leuven, Belgium, Belgium

816 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 28 Feb 2003
Primary completion: 30 Sept 2008
Completion: 30 Sept 2008
Last update posted: 24 Mar 2014
Registered enrollment: 17,802
Registry id: NCT00239681

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.